Bioabsorbable Therapeutics Overview

  • Year Founded
  • 2004

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Bioabsorbable Therapeutics General Information

Description

Developer of absorbable stent to treat vascular disease. The company utilizes novel, proprietary anti-inflammatory polymers to create fully bioabsorbable coatings and stents.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 959 Hamilton Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650)
Primary Industry
Therapeutic Devices
Other Industries
Other Devices and Supplies
Acquirer
Xenogenics
Vertical(s)
Corporate Office
  • 959 Hamilton Avenue
  • Menlo Park, CA 94025
  • United States
+1 (650)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Bioabsorbable Therapeutics Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Merger/Acquisition 30-Sep-2010 Completed Generating Revenue
3. Early Stage VC 13-Mar-2009 Completed Generating Revenue
2. Early Stage VC (Series B) 10-May-2007 $9M $9.4M Completed Generating Revenue
1. Early Stage VC (Series A) 07-Feb-2006 $420K $420K Completed Product Development
To view Bioabsorbable Therapeutics’s complete valuation and funding history, request access »

Bioabsorbable Therapeutics Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion Price % Owned
Series B
Series A
To view Bioabsorbable Therapeutics’s complete cap table history, request access »

Bioabsorbable Therapeutics Patents

Bioabsorbable Therapeutics Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2009126244-A2 Devices, systems, and methods for joining body conduits Inactive 07-Apr-2008
WO-2009126244-A3 Devices, systems, and methods for joining body conduits Inactive 07-Apr-2008
WO-2009089072-A1 Braided, biodegradable stents and methods Inactive 11-Jan-2008
CA-2667325-A1 A drug-release composition having a therapeutic carrier Inactive 23-Oct-2006
WO-2008051565-A2 A drug-release composition having a therapeutic carrier Inactive 23-Oct-2006 A61K45/06
To view Bioabsorbable Therapeutics’s complete patent history, request access »

Bioabsorbable Therapeutics Former Investors (9)

Investor Name Investor Type Holding Investor Since Participating Rounds
BioStar Capital Venture Capital Minority
Finistere Ventures Venture Capital Minority
MedFocus Venture Capital Minority
Olympus Business Creation America Corporate Venture Capital Minority
Scotasian Capital Venture Capital Minority
You’re viewing 5 of 9 investors. Get the full list »

Bioabsorbable Therapeutics FAQs

  • When was Bioabsorbable Therapeutics founded?

    Bioabsorbable Therapeutics was founded in 2004.

  • Where is Bioabsorbable Therapeutics headquartered?

    Bioabsorbable Therapeutics is headquartered in Menlo Park, CA.

  • What industry is Bioabsorbable Therapeutics in?

    Bioabsorbable Therapeutics’s primary industry is Therapeutic Devices.

  • Is Bioabsorbable Therapeutics a private or public company?

    Bioabsorbable Therapeutics is a Private company.

  • What is Bioabsorbable Therapeutics’s current revenue?

    The current revenue for Bioabsorbable Therapeutics is .

  • How much funding has Bioabsorbable Therapeutics raised over time?

    Bioabsorbable Therapeutics has raised $9.8M.

  • Who are Bioabsorbable Therapeutics’s investors?

    BioStar Capital, Finistere Ventures, MedFocus, Olympus Business Creation America, and Scotasian Capital are 5 of 9 investors who have invested in Bioabsorbable Therapeutics.

  • When was Bioabsorbable Therapeutics acquired?

    Bioabsorbable Therapeutics was acquired on 30-Sep-2010.

  • Who acquired Bioabsorbable Therapeutics?

    Bioabsorbable Therapeutics was acquired by Xenogenics.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process